224 related articles for article (PubMed ID: 28653250)
1. Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance).
Bluethmann SM; Alfano CM; Clapp JD; Luta G; Small BJ; Hurria A; Cohen HJ; Sugarman S; B Muss H; Isaacs C; Mandelblatt JS
Breast Cancer Res Treat; 2017 Oct; 165(3):677-686. PubMed ID: 28653250
[TBL] [Abstract][Full Text] [Related]
2. Understanding Breast Cancer Survivors' Beliefs and Concerns About Adjuvant Hormonal Therapy: Promoting Adherence.
Hurtado-de-Mendoza A; Jensen RE; Jennings Y; Sheppard VB
J Cancer Educ; 2018 Apr; 33(2):436-439. PubMed ID: 28205022
[TBL] [Abstract][Full Text] [Related]
3. Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901.
Sheppard VB; Faul LA; Luta G; Clapp JD; Yung RL; Wang JH; Kimmick G; Isaacs C; Tallarico M; Barry WT; Pitcher BN; Hudis C; Winer EP; Cohen HJ; Muss HB; Hurria A; Mandelblatt JS
J Clin Oncol; 2014 Aug; 32(22):2318-27. PubMed ID: 24934786
[TBL] [Abstract][Full Text] [Related]
4. Symptom burden among older breast cancer survivors: The Thinking and Living With Cancer (TLC) study.
Mandelblatt JS; Zhai W; Ahn J; Small BJ; Ahles TA; Carroll JE; Denduluri N; Dilawari A; Extermann M; Graham D; Hurria A; Isaacs C; Jacobsen PB; Jim HSL; Luta G; McDonald BC; Patel SK; Root JC; Saykin AJ; Tometich DB; Zhou X; Cohen HJ
Cancer; 2020 Mar; 126(6):1183-1192. PubMed ID: 31860135
[TBL] [Abstract][Full Text] [Related]
5. Ageing perceptions and non-adherence to aromatase inhibitors among breast cancer survivors.
Brier MJ; Chambless DL; Chen J; Mao JJ
Eur J Cancer; 2018 Mar; 91():145-152. PubMed ID: 29329697
[TBL] [Abstract][Full Text] [Related]
6. Personality, coping, and social support as predictors of long-term quality-of-life trajectories in older breast cancer survivors: CALGB protocol 369901 (Alliance).
Durá-Ferrandis E; Mandelblatt JS; Clapp J; Luta G; Faul L; Kimmick G; Cohen HJ; Yung RL; Hurria A
Psychooncology; 2017 Nov; 26(11):1914-1921. PubMed ID: 28219113
[TBL] [Abstract][Full Text] [Related]
7. Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study.
van der Willik KD; Koppelmans V; Hauptmann M; Compter A; Ikram MA; Schagen SB
Breast Cancer Res; 2018 Nov; 20(1):135. PubMed ID: 30442190
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast Cancer.
He W; Fang F; Varnum C; Eriksson M; Hall P; Czene K
J Clin Oncol; 2015 Jul; 33(20):2262-9. PubMed ID: 26033800
[TBL] [Abstract][Full Text] [Related]
9. Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study.
Underwood EA; Jerzak KJ; Lebovic G; Rochon PA; Elser C; Pritchard KI; Tierney MC
Support Care Cancer; 2019 Aug; 27(8):3035-3043. PubMed ID: 30610433
[TBL] [Abstract][Full Text] [Related]
10. Post-treatment Neurocognition and Psychosocial Care Among Breast Cancer Survivors.
Buchanan ND; Dasari S; Rodriguez JL; Lee Smith J; Hodgson ME; Weinberg CR; Sandler DP
Am J Prev Med; 2015 Dec; 49(6 Suppl 5):S498-508. PubMed ID: 26590645
[TBL] [Abstract][Full Text] [Related]
11. The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients.
Gregorowitsch ML; Ghedri A; Young-Afat DA; Bijlsma R; Baas IO; van Schaik-van de Mheen C; Agterof MJ; Göker E; Ten Bokkel Huinink D; van den Bongard HJGD; Verkooijen HM;
Breast Cancer Res Treat; 2019 Jun; 175(2):429-441. PubMed ID: 30746636
[TBL] [Abstract][Full Text] [Related]
12. Cognitive function prior to systemic therapy and subsequent well-being in older breast cancer survivors: Longitudinal findings from the Thinking and Living with Cancer Study.
Kobayashi LC; Cohen HJ; Zhai W; Zhou X; Small BJ; Luta G; Hurria A; Carroll J; Tometich D; McDonald BC; Graham D; Jim HSL; Jacobsen P; Root JC; Saykin AJ; Ahles TA; Mandelblatt J
Psychooncology; 2020 Jun; 29(6):1051-1059. PubMed ID: 32154959
[TBL] [Abstract][Full Text] [Related]
13. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.
Hershman DL; Kushi LH; Shao T; Buono D; Kershenbaum A; Tsai WY; Fehrenbacher L; Gomez SL; Miles S; Neugut AI
J Clin Oncol; 2010 Sep; 28(27):4120-8. PubMed ID: 20585090
[TBL] [Abstract][Full Text] [Related]
14. An Examination of the Longitudinal Relationship Between Cognitive Function and Physical Activity Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study.
Tometich DB; Mosher CE; Cyders M; McDonald BC; Saykin AJ; Small BJ; Zhai W; Zhou X; Jim HSL; Jacobsen P; Ahles TA; Root JC; Graham D; Patel SK; Mandelblatt J
Ann Behav Med; 2023 Apr; 57(3):237-248. PubMed ID: 36356044
[TBL] [Abstract][Full Text] [Related]
15. Exploring the role of social support and adjuvant endocrine therapy use among breast cancer survivors.
Toledo G; Ochoa CY; Farias AJ
Support Care Cancer; 2020 Jan; 28(1):271-278. PubMed ID: 31037379
[TBL] [Abstract][Full Text] [Related]
16. Treatment interruption and discontinuation of hormonal therapy in hormone receptor-positive breast cancer patients.
Mao D; Hachem H; Chang H; Dima D; Dower J; Wismer M; Erban JK; Freund KM; Parsons SK
Breast Cancer Res Treat; 2020 Dec; 184(3):665-674. PubMed ID: 32918658
[TBL] [Abstract][Full Text] [Related]
17. Self-reported cognitive decline in Japanese patients with breast cancer treated with endocrine therapy.
Yamamoto S; Masutani E; Arao H
Breast Cancer; 2020 Jul; 27(4):670-682. PubMed ID: 32114664
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant endocrine therapy for breast cancer patients: impact of a health system outreach program to improve adherence.
Lee C; Check DK; Manace Brenman L; Kushi LH; Epstein MM; Neslund-Dudas C; Pawloski PA; Achacoso N; Laurent C; Fehrenbacher L; Habel LA
Breast Cancer Res Treat; 2020 Feb; 180(1):219-226. PubMed ID: 31975315
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant radiation therapy alone is associated with improved overall survival compared to hormonal therapy alone in older women with estrogen receptor positive early stage breast cancer.
Jhawar SR; Alpert N; Taioli E; Sayan M; Bazan J; Park KU; Stover D; Cherian M; White J; Haffty B; Ohri N
Cancer Med; 2020 Nov; 9(22):8345-8354. PubMed ID: 32942344
[TBL] [Abstract][Full Text] [Related]
20. Adherence to adjuvant endocrine therapy among breast cancer survivors: a systematic review and meta-synthesis of the qualitative literature using grounded theory.
AlOmeir O; Patel N; Donyai P
Support Care Cancer; 2020 Nov; 28(11):5075-5084. PubMed ID: 32601852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
